1768MO Incidence of fracture related hospitalisations in men with de novo high risk localised and metastatic hormone sensitive prostate cancer: Analysis of routinely collected healthcare data from the STAMPEDE docetaxel and zoledronic acid comparisonsCraig Jones, Ashwin Sachdeva, Peter Dutey‐Magni et al.|Annals of Oncology|2023Cited by 5
Plasma <i>AR</i> Alterations and Timing of Intensified Hormone Treatment for Prostate CancerGianmarco Leone, Osvaldas Vainauskas, Emily Grist et al.|JAMA Oncology|2025Cited by 5